McNally Lisa M, Jeena Prakash M, Gajee Kavitha, Thula Stanley A, Sturm A Willem, Cassol Sharon, Tomkins Andrew M, Coovadia Hoosen M, Goldblatt David
Centre for International Child Health and Development, Institute of Child Health, University College London, London WC1N 1EH, UK; Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Lancet. 2007 Apr 28;369(9571):1440-1451. doi: 10.1016/S0140-6736(07)60670-9.
HIV-related pneumonia is the main cause of paediatric hospital admissions in southern Africa. We aimed to measure predictors of treatment failure and the cause of non-responsive pneumonia in children admitted to hospital with severe pneumonia in Durban, South Africa.
We investigated 358 children aged 1-59 months who presented with WHO-defined severe or very severe pneumonia. Children were recruited irrespective of HIV status and started on a standard antimicrobial regimen of benzylpenicillin and gentamicin. All infants also received high-dose trimethoprim-sulfamethoxazole. The primary outcome measure was treatment failure at 48 h.
242 (68%) children were HIV infected, 41 (12%) HIV exposed, uninfected, and 75 (21%) HIV uninfected. Failure to respond by 48 h was predicted by age under 1 year (adjusted odds ratio 6.38, 95% CI 2.72-14.91, p<0.0001), very severe disease (2.47, 1.17-5.24, p=0.0181), HIV status (HIV infected 10.3, 3.26-32.51; HIV exposed, uninfected 6.02, 1.55-23.38; p=0.0003), and polymicrobial disease (one organism 2.06, 1.05-4.05; two organisms 10.75, 4.38-26.36; p<0.0001) on logistic regression analysis. All children with three organisms failed treatment. 72/110 treatment failures had at least two organisms isolated. Three of nine HIV-exposed, uninfected infants, 29/74 HIV-infected, but no HIV-uninfected infants who failed study therapy had Pneumocystis jirovecii pneumonia.
For children younger than 1 year, the WHO guidelines are inadequate and need to be revised since both HIV-infected and HIV-exposed, uninfected infants had more treatment failures than did HIV-uninfected infants. Polymicrobial disease is an important reason for treatment failure, and we need to identify rapid low-cost diagnostic methods to assist clinicians.
在非洲南部,与艾滋病病毒相关的肺炎是儿科住院的主要原因。我们旨在测定南非德班因严重肺炎住院儿童治疗失败的预测因素以及无反应性肺炎的病因。
我们调查了358名年龄在1至59个月、出现世界卫生组织定义的严重或非常严重肺炎的儿童。招募儿童时不考虑其艾滋病病毒感染状况,并开始使用苄青霉素和庆大霉素的标准抗菌方案进行治疗。所有婴儿还接受了高剂量的甲氧苄啶 - 磺胺甲恶唑治疗。主要结局指标是48小时时的治疗失败情况。
242名(68%)儿童感染了艾滋病病毒,41名(12%)暴露于艾滋病病毒但未感染,75名(21%)未感染艾滋病病毒。1岁以下年龄(校正比值比6.38,95%置信区间2.72 - 14.91,p<0.0001)、非常严重的疾病(2.47,1.17 - 5.24,p = 0.0181)、艾滋病病毒感染状况(感染艾滋病病毒10.3,3.26 - 32.51;暴露于艾滋病病毒但未感染6.02,1.55 - 23.38;p = 0.0003)以及多微生物疾病(一种微生物2.06,1.05 - 4.05;两种微生物10.75,4.38 - 26.36;p<0.0001)在逻辑回归分析中是48小时时无反应的预测因素。所有感染三种微生物的儿童治疗均失败。110例治疗失败的儿童中有72例至少分离出两种微生物。9名暴露于艾滋病病毒但未感染的婴儿中有3例、74名感染艾滋病病毒但研究治疗失败的婴儿中有29例,而未感染艾滋病病毒的婴儿中无治疗失败的婴儿患有耶氏肺孢子菌肺炎。
对于1岁以下儿童,世界卫生组织的指南并不充分,需要修订,因为感染艾滋病病毒和暴露于艾滋病病毒但未感染的婴儿治疗失败的情况均多于未感染艾滋病病毒的婴儿。多微生物疾病是治疗失败的一个重要原因,我们需要确定快速、低成本的诊断方法以协助临床医生。